ValiRx (VAL) Competitors GBX 0.52 +0.02 (+4.80%) As of 04/17/2025 11:13 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock VAL vs. HNR, EOG, SUN, WRES, EQT, CRC, WEB, NBL, FTO, and TXOShould you be buying ValiRx stock or one of its competitors? The main competitors of ValiRx include Highlands Natural Resources (HNR), Europa Oil & Gas (EOG), Surgical Innovations Group (SUN), W Resources (WRES), EQTEC (EQT), Circle Property (CRC), Webis (WEB), 18564 (NBL.L) (NBL), 2059984 (FTO.L) (FTO), and 282082 (TXO.L) (TXO). These companies are all part of the "petroleum and natural gas" industry. ValiRx vs. Highlands Natural Resources Europa Oil & Gas Surgical Innovations Group W Resources EQTEC Circle Property Webis 18564 (NBL.L) 2059984 (FTO.L) 282082 (TXO.L) ValiRx (LON:VAL) and Highlands Natural Resources (LON:HNR) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, community ranking, valuation, dividends, institutional ownership, risk, earnings, analyst recommendations and media sentiment. Does the MarketBeat Community favor VAL or HNR? ValiRx received 109 more outperform votes than Highlands Natural Resources when rated by MarketBeat users. However, 58.57% of users gave Highlands Natural Resources an outperform vote while only 51.55% of users gave ValiRx an outperform vote. CompanyUnderperformOutperformValiRxOutperform Votes15051.55% Underperform Votes14148.45% Highlands Natural ResourcesOutperform Votes4158.57% Underperform Votes2941.43% Does the media refer more to VAL or HNR? In the previous week, Highlands Natural Resources' average media sentiment score of 0.45 beat ValiRx's score of 0.00 indicating that Highlands Natural Resources is being referred to more favorably in the news media. Company Overall Sentiment ValiRx Neutral Highlands Natural Resources Neutral Is VAL or HNR more profitable? Highlands Natural Resources has a net margin of 0.00% compared to ValiRx's net margin of -20,554.01%. Highlands Natural Resources' return on equity of 0.00% beat ValiRx's return on equity.Company Net Margins Return on Equity Return on Assets ValiRx-20,554.01% -55.84% -35.98% Highlands Natural Resources N/A N/A N/A Which has stronger earnings and valuation, VAL or HNR? Highlands Natural Resources has higher revenue and earnings than ValiRx. ValiRx is trading at a lower price-to-earnings ratio than Highlands Natural Resources, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioValiRx£27.78K71.61-£5.71M-£1.48-0.35Highlands Natural Resources£1.02M0.00N/A-£4.90N/A SummaryHighlands Natural Resources beats ValiRx on 6 of the 9 factors compared between the two stocks. Get ValiRx News Delivered to You Automatically Sign up to receive the latest news and ratings for VAL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VAL vs. The Competition Export to ExcelMetricValiRxBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£1.99M£121.10M£5.31B£2.51BDividend Yield0.63%3.75%5.45%4.79%P/E Ratio-0.353.0521.94130.39Price / Sales71.614,230.36380.95234,570.21Price / Cash62.5013.1938.2628.26Price / Book0.2034.276.454.42Net Income-£5.71M-£91.73M£3.22B£5.88B1 Month Performance-10.88%-5.05%-9.76%-1.35%1 Year Performance-84.81%84.00%11.49%41.32% ValiRx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VALValiRxN/AGBX 0.52+4.8%N/A-84.8%£1.99M£27,777.32-0.355,450Gap DownHNRHighlands Natural ResourcesN/AN/AN/AN/A£6.95M£1.02M-0.9616News CoverageGap DownHigh Trading VolumeEOGEuropa Oil & GasN/AGBX 0.63+4.8%N/A-32.9%£6.03M£3.57M-0.892,850Gap UpSUNSurgical Innovations GroupN/AGBX 0.47-6.8%N/A-9.1%£4.35M£12.54M-21.1180Gap UpWRESW ResourcesN/AN/AN/AN/A£3.89M£3.47M-0.4366Gap DownEQTEQTECN/AGBX 0.73+2.1%N/A-63.3%£1.88M£3.85M-4.29740High Trading VolumeCRCCircle PropertyN/AN/AN/AN/A£1.02M£7.57M50.001,060Gap DownHigh Trading VolumeWEBWebisN/AN/AN/AN/A£157,000.00£49.70M14.1350Gap DownNBL18564 (NBL.L)N/AN/AN/AN/A£0.00N/A0.002,330FTO2059984 (FTO.L)N/AN/AN/AN/A£0.00N/A0.00147,000TXO282082 (TXO.L)N/AN/AN/AN/A£0.00N/A0.00170 Related Companies and Tools Related Companies Highlands Natural Resources Alternatives Europa Oil & Gas Alternatives Surgical Innovations Group Alternatives W Resources Alternatives EQTEC Alternatives Circle Property Alternatives Webis Alternatives 18564 (NBL.L) Alternatives 2059984 (FTO.L) Alternatives 282082 (TXO.L) Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:VAL) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ValiRx plc Please log in to your account or sign up in order to add this asset to your watchlist. Share ValiRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VAL Stock Free VAL Stock Alerts